Skip to content
Home/Companies/Pharma/Corealis
CO

Corealis

Pharma·Canada·Active·4yr hold

Corealis is a pharma services company, headquartered in Canada.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Corealis?

Corealis is currently owned by ARCHIMED through MED Platform II (2022 vintage), since 2022.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform II · 2022 · Buyout

Key facts

HQCanada
SectorPharma Services

More from MED Platform II

Other portfolio companies in the same fund.

ARK Diagnostics
Active
MedTechUS· 2025
Instem
Active
HealthTechUS· 2023
Symbio
Active
PharmaUS· 2023
WiQo
Active
HealthTechItaly· 2023
Natus
Active
MedTechUS· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Forth Therapeutics
Active
Old College CapitalUK· 2025
Data refreshed weekly · Sourced from public filings